Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients

BACKGROUND: We characterized the pharmacogenomics (PGx) results received by diagnostic odyssey patients as secondary findings during clinical whole exome sequencing (WES) testing as a part of their care in Mayo Clinic's Individualized Medicine Clinic to determine the potential benefits and limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousin, Margot A., Matey, Eric T., Blackburn, Patrick R., Boczek, Nicole J., McAllister, Tammy M., Kruisselbrink, Teresa M., Babovic‐Vuksanovic, Dusica, Lazaridis, Konstantinos N., Klee, Eric W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441410/
https://www.ncbi.nlm.nih.gov/pubmed/28546997
http://dx.doi.org/10.1002/mgg3.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441410/
https://www.ncbi.nlm.nih.gov/pubmed/28546997
http://dx.doi.org/10.1002/mgg3.283

Ejemplares similares